Clinical trial
An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of Conbercept Eye Drops in Patients With Corneal Neovascularization
NCT04215393 is registered in ClinicalTrials.gov with Chengdu Kanghong Biotech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of Conbercept Eye Drops in Patients With Corneal Neovascularization
- Lead sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- July 18, 2019
- Completion date
- December 31, 2020
- Enrollment
- 39 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.